| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |